EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical translation of gold nanoparticles

Rui Zhang, Fabian Kiessling, Twan Lammers, Roger M Pallares iD

Drug Delivery and Translational Research · 2023-02 · 13 (2) · 378-385

DOI: 10.1007/s13346-022-01232-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 31.08.2022. Verfasst von Rui Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, 52074, Aachen, Germany. Hauptthemen laut MEDLINE: Metal Nanoparticles, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 198-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Ministerium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen, Bundesministerium für Bildung und Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gold nanoparticles display unique physicochemical features, which can be useful for therapeutic purposes. After two decades of preclinical progress, gold nanoconstructs are slowly but steadily transitioning into clinical trials. Although initially thought to be “magic golden bullets” that could be used to treat a wide range of diseases, current consensus has moved toward a more realistic approach, where gold nanoformulations are being investigated to treat specific disorders. These therapeutic applications are dictated by the pharmacokinetics and biodistribution profiles of gold nanoparticles. Here, we analyze the current clinical landscape of therapeutic gold nanoconstructs, discuss the shared characteristics that allowed for their transition from bench to bedside, and examine existing hurdles that need to be overcome before they can be approved for clinical use. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal NanoparticlesNanoparticlesNeoplasmsHumansGoldTissue DistributionNanomedicine

Stichwörter der Autor:innen

Clinical trialsDrug deliveryGold nanoconstructsGold nanoparticlesNanomedicinePhotothermal therapy

Substanzen

Gold

Autor:innen und Institutionen

  • Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, 52074, Aachen, Germany.
  • Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, 52074, Aachen, Germany. rmoltopallar@ukaachen.de.

ORCID-Profile: Roger M Pallares

Förderung

  • European Research Council
  • Ministerium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen
  • Bundesministerium für Bildung und Forschung
  • German Research Foundation
  • Deutsche Forschungsgemeinschaft
  • RWTH Aachen University

Zitieren

APA

Zhang, R., Kiessling, F., Lammers, T., & Pallares, R. M. (2023). Clinical translation of gold nanoparticles. Drug Delivery and Translational Research, 13(2), 378-385. https://doi.org/10.1007/s13346-022-01232-4

Vancouver

Zhang R, Kiessling F, Lammers T, Pallares RM. Clinical translation of gold nanoparticles. Drug Delivery and Translational Research. 2023;13(2):378-385. doi:10.1007/s13346-022-01232-4

BibTeX
@article{Zhang2023,
  author = {Zhang, Rui and Kiessling, Fabian and Lammers, Twan and Pallares, Roger M},
  title = {Clinical translation of gold nanoparticles},
  journal = {Drug Delivery and Translational Research},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {378--385},
  doi = {10.1007/s13346-022-01232-4}
}
Kostenlos starten →